These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 12972011

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Evaluation of the tocolytic effect of a selective cyclooxygenase-2 inhibitor in a mouse model of lipopolysaccharide-induced preterm delivery.
    Sakai M, Tanebe K, Sasaki Y, Momma K, Yoneda S, Saito S.
    Mol Hum Reprod; 2001 Jun; 7(6):595-602. PubMed ID: 11385116
    [Abstract] [Full Text] [Related]

  • 3. Prostaglandin inhibitors as tocolytic agents.
    Vermillion ST, Landen CN.
    Semin Perinatol; 2001 Aug; 25(4):256-62. PubMed ID: 11561913
    [Abstract] [Full Text] [Related]

  • 4. Effect of selective vs. non-selective cyclo-oxygenase inhibitors on fetal membrane prostaglandin synthesis.
    Sawdy R, Pan H, Sullivan M, Bennett P.
    J Obstet Gynaecol; 2003 May; 23(3):239-43. PubMed ID: 12850850
    [Abstract] [Full Text] [Related]

  • 5. Cyclooxygenase inhibitors for treating preterm labour: What is the molecular evidence? 1.
    Urrego D, Liwa AC, Cole WC, Wood SL, Slater DM.
    Can J Physiol Pharmacol; 2019 Mar; 97(3):222-231. PubMed ID: 30661374
    [Abstract] [Full Text] [Related]

  • 6. Cyclooxygenase-1-selective inhibition prolongs gestation in mice without adverse effects on the ductus arteriosus.
    Loftin CD, Trivedi DB, Langenbach R.
    J Clin Invest; 2002 Aug; 110(4):549-57. PubMed ID: 12189249
    [Abstract] [Full Text] [Related]

  • 7. Can a cyclo-oxygenase type-2 selective tocolytic agent avoid the fetal side effects of indomethacin?
    Locatelli A, Vergani P, Bellini P, Strobelt N, Ghidini A.
    BJOG; 2001 Mar; 108(3):325-6. PubMed ID: 11281476
    [Abstract] [Full Text] [Related]

  • 8. Experience of the use of nimesulide, a cyclo-oxygenase-2 selective prostaglandin synthesis inhibitor, in the prevention of preterm labour in 44 high-risk cases.
    Sawdy RJ, Groom KM, Bennett PR.
    J Obstet Gynaecol; 2004 Apr; 24(3):226-9. PubMed ID: 15203612
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Indomethacin in pregnancy: applications and safety.
    Abou-Ghannam G, Usta IM, Nassar AH.
    Am J Perinatol; 2012 Mar; 29(3):175-86. PubMed ID: 21786219
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Fetal cardiac function and ductus arteriosus during indomethacin and sulindac therapy for threatened preterm labor: a randomized study.
    Räsänen J, Jouppila P.
    Am J Obstet Gynecol; 1995 Jul; 173(1):20-5. PubMed ID: 7631682
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.